Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
On Mar 15, we downgraded our recommendation on StanCorp Financial Group Inc. (SFG - Analyst Report) to Neutral based on higher group insurance benefit ratio and lower premiums. This life insurer currently carries a Zacks Rank #3 (Hold).
Why the Downgrade?
After reporting strong growth in group insurance premiums, StanCorp witnessed a decline in premiums for the last two quarters. The decline largely stemmed from a low single-digit price increase in its group insurance business and stiff competition, which also weighed on new sales and renewals. Persistency also declined compared with 2011.
In 2012, delinquency improved to 0.40% from 0.34% in 2011.
Benefit ratio was 83.7% in the fourth quarter (up from 82.8% in the year-ago quarter) and was 83.9% for full year 2012, both exceeding the guided range of 80%–82%.
Causes for Concern
StanCorp also expects headwinds from the lack of employment and wage growth in the group insurance business to persist in the upcoming quarters and pressurize premium growth. StanCorp expects group insurance premium to decrease in low-single digit in 2013, exerting downward pressure on group insurance sales and persistency.
Group insurance benefit ratio is expected between 81% and 84% in 2013.
Insurance Stocks That Warrant a Look
Other insurance stocks worth a look are Reinsurance Group of America Inc. (RGA - Analyst Report), Principal Financial Group Inc. (PFG - Analyst Report) and Aegon N. V. (AEG - Snapshot Report). All these stocks carry a Zacks Rank #2 (Buy).
Get the full Analyst Report on SFG - FREE
Get the full Snapshot Report on AEG - FREE
Get the full Analyst Report on PFG - FREE
Get the full Analyst Report on RGA - FREE